Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.27.534309Source: DataRank Database

Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (33)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (20)

Misako Nagasaka ORCID,Amro Aboukameel,Osama Alkhalili ORCID,Md. Hafiz Uddin ORCID,Sahar F. Bannoura ORCID

Live enrichment

PubMed:37034616 OpenAlex:https://openalex.org/W4361018490

National Institutes of Health

Grant: 5R01CA240607-04

A novel therapy for pancreatic neuroendocrine tumors

National Institutes of Health

Grant: 5R37CA215427-04

Clinical Translation of Nuclear Export Inhibitor in Metastatic Pancreatic Cancer

greenLicense: CC BY NC ND

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2023/03/27/2023.03.27.534309.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.03.27.534309

repositoryhttps://doi.org/10.1101/2023.03.27.534309

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37034616

Fields of Study

Protein Kinase Regulation and GTPase SignalingPeptidase Inhibition and AnalysisCancer-related Molecular Pathways03 medical and health sciences0302 clinical medicine

Keywords

KRASMedicineCancer researchPancreatic cancerPharmacologyErlotinibCancerMutantInternal medicineChemistryEpidermal growth factor receptorColorectal cancerLung NeoplasmsAcetonitrilesCarcinoma610PiperazinesPancreatic NeoplasmsProto-Oncogene Proteins p21(ras)Pyrimidinesp21-Activated KinasesPancreatic DuctalCarcinoma, Non-Small-Cell LungHumansSmall Molecule TherapeuticsNon-Small-Cell LungProtein Kinase InhibitorsCarcinoma, Pancreatic Ductal

Sustainable Development Goals

SDG 0: Good health and well-being